Skip to main content
US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
ZT

ZTSStockZoetis Inc - Ordinary Shares - Class A

New York Stock Exchange · Healthcare · US

$82.11 last close 2026-11-05
Open in terminalCompare
Alert

Verdicts genuinely change. Free email alert the moment ZTS's does — no target price to set, unlike "Alert" above.

Sharia status
NOT COMPLIANT
Per our secondary compliance provider · assessed 2026-08-12
4 of 7 pass our own screen — the standards disagree
HTR non-permissible income 0.98%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure2 of 5 timeframes bullish · 69.6% aligned
VWAPPrice below VWAP ($84.35)
VolumeRelative volume 11.1× the 20-day average
Momentum10-day rate of change +5.2%

Zoetis Inc - Ordinary Shares - Class A (ZTS) is currently considered not halal (non-compliant), per our secondary compliance provider (last assessed 2026-08-12). See the full ratio breakdown and business-activity screen below for the reasoning.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

451 other Healthcare stocks pass this same screen. See compliant Healthcare stocks →

Market & analysts
Wall Street consensus
HOLD
24 analysts
Institutional own.
100.3% *
of shares
Momentum (10d)
+5.2%
rate of change
SMC grade
B · 67
69.6% aligned
0.98%
Non-permissible income — HTR, from filings (2026-06-30)
B · 67
SMC grade — 69.6% timeframe alignment
+5.2%
Rate of change (10d)
HOLD
Wall Street consensus (24)
100.3%
Institutional ownership *

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-06-30. These ratios come from the issuer's own published statements rather than structured SEC data.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass 3 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 28.98% 30.00% Pass
Interest-bearing investments 5.26% 30.00% Pass
Non-permissible income 0.98% 5.00% Pass
Usmani Fail 3 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 61.27% 33.00% Fail
Interest-bearing investments 11.12% 33.00% Pass
Non-liquid assets 78.46% at least 20.00% Pass
Non-permissible income 0.98% 5.00% Pass
MSCI Fail 3 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 61.27% 33.33% Fail
Cash + interest-bearing securities 11.12% 33.33% Pass
Accounts receivable 21.54% 33.33% Pass
Non-permissible income 0.98% 5.00% Pass
FTSE Fail 3 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 60.01% 33.33% Fail
Cash + interest-bearing securities 11.12% 33.33% Pass
Accounts receivable 21.54% 50.00% Pass
Non-permissible income 0.98% 5.00% Pass
Dow Jones Islamic Market Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 18.88% 33.00% Pass
Cash + interest-bearing securities 3.42% 33.00% Pass
Accounts receivable 3.21% 33.00% Pass
Non-permissible income 0.98% 5.00% Pass
S&P Shariah Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 16.79% 33.00% Pass
Cash + interest-bearing securities 3.05% 49.00% Pass
Accounts receivable 2.85% 49.00% Pass
Non-permissible income 0.98% 5.00% Pass
MSCI M-Series Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 16.79% 33.33% Pass
Cash + interest-bearing securities 3.05% 33.33% Pass
Accounts receivable 5.90% 49.00% Pass
Non-permissible income 0.98% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

AAOIFI Standard 21 (% of market cap)debt ratio 1.0pts
AAOIFI Standard 21 (% of market cap)non permissible income ratio 4.0pts
Usmani (% of total assets)non permissible income ratio 4.0pts
Usmani (% of total assets)debt ratio 28.3pts
MSCI Islamic Index (% of total assets)debt ratio 27.9pts
FTSE Shariah Global Equity Index Series (% of total assets)debt ratio 26.7pts

The numbers the ratios are built from

Read from ZTS's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $9.5B 2026-06-30 Revenues
Interest-bearing debtShort and long-term borrowings $9.0B 2026-06-30 LongTermDebtNoncurrent
Cash and interest-bearing securitiesCash, equivalents and marketable securities $1.7B 2026-06-30 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents, ShortTermInvestments
Total assetsBalance sheet total $15.1B 2026-06-30 Assets
Market capDenominator for AAOIFI $31.9B live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $66.2B 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $60.0B 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $93.0M 2026-06-30 10-K text (no XBRL tag available)

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

What changed, and when

Verdict history for ZTS. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-09-07 Compliant → Non Compliant watchlist re-scan

ℹ️ no compliance scan has run for 3 days - this is not a reading of today

Tracked investors holding ZTS
InvestorFirmPositionWeightAs of
Tweedy, Browne Tweedy, Browne Company $40M 3.0% 2026-06-30
Ray Dalio Bridgewater Associates $10M 0.0% 2026-06-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

128.76113.7398.7083.6768.642025-11-062026-05-082026-11-05

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
81.80
S2
83.31
S1
86.26
PIVOT
87.77
R1
90.72
R2
92.23
R3
95.18

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
65.81 – 74.79
±6.39% from 70.30, made 2026-09-29 · resolves 2026-10-06
STRONG SELL
from 19 indicators
61.9% of our last 5789 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 49.9% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG BUY
19 indicators
OscillatorsSTRONG BUY
3 buy · 3 neutral · 1 sell
Moving averagesSTRONG BUY
10 buy · 0 neutral · 2 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)57.30NEUTRAL
Stochastic %K (14)43.81NEUTRAL
CCI (20)131.76SELL
Williams %R (14)-56.19NEUTRAL
MACD (12,26,9)0.53BUY
ROC (10)0.81BUY
Momentum (10)0.66BUY
EMA (10)81.75BUY
SMA (10)81.14BUY
EMA (20)79.50BUY
SMA (20)79.26BUY
EMA (30)78.12BUY
SMA (30)76.31BUY
EMA (50)77.00BUY
SMA (50)75.15BUY
EMA (100)79.25BUY
SMA (100)75.08BUY
EMA (200)92.05SELL
SMA (200)91.52SELL

About Zoetis Inc - Ordinary Shares - Class A

Healthcare · Drug Manufacturers - Specialty & Generic

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.

zoetis.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Grade verdict

Good setup, solid confluence

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BULLISH 64
⏰ 4H BULLISH 45
🕐 1H BEARISH 98
⏱ 15-Min BEARISH 130
⏲ 5-Min BEARISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

+5.2%
Rate of change (10d)
11.1×
Volume vs its 20-day average
2.85
MACD (no fresh cross)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NEUTRAL   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-10-27 · Asset managers net 923449 (+22072)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.